Antimicrobial Drug Use and Methicillin-resistant<i>Staphylococcus aureus</i>, Aberdeen, 1996–2000

Dominique L. Monnet(European Centre for Disease Prevention and Control), Ian M. Gould(Aberdeen Royal Infirmary), Arielle Beyaert(Universidad de Murcia), David I. Stuart(MRC Laboratory of Molecular Biology), R. Wilson(Aberdeen Royal Infirmary), Fiona Mackenzie(Aberdeen Royal Infirmary), José-Marı́a López-Lozano(Hospital Vega Baja), Máximo Camacho(Universidad de Murcia)
Emerging infectious diseases
August 1, 2004
10.3201/eid1008.020694
Cited by 182

Related Papers

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
|Cell|2022|762
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661
Self-medication with Antimicrobial Drugs in Europe
|Emerging infectious diseases|2006|595